Marijuana Inc. (MAJI)

OTCMKTS · Delayed Price · Currency is USD
0.1650
-0.0350 (-17.50%)
Apr 25, 2025, 4:00 PM EDT
132.39%
Market Cap 5.79M
Revenue (ttm) n/a
Net Income (ttm) -854.02K
Shares Out 35.09M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 14,100
Average Volume 174,325
Open 0.2000
Previous Close 0.2000
Day's Range 0.1600 - 0.2000
52-Week Range 0.0050 - 0.3200
Beta -3.94
RSI 51.53
Earnings Date n/a

About Marijuana

Marijuana Inc. distributes cannabis products in the United States. The company was formerly known as GRN Holding Corporation and changed its name to Marijuana Inc. in October 2024. Marijuana Inc. was founded in 2010 and is based in Estero, Florida. [Read more]

Sector Healthcare
Founded 2010
Country United States
Stock Exchange OTCMKTS
Ticker Symbol MAJI
Full Company Profile

Financial Performance

Financial Statements

News

Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview

A published paper shows NANOG Expression was almost 100% effective at eradicating tumor cells ORLANDO, FL / ACCESS Newswire / April 21, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a ...

6 days ago - Accesswire

Exousia Pro Offers Guidance on New Subdivisions

ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is p...

10 days ago - Accesswire

Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show

Exousia Pro has a 60% margin built-in on each order of exosomes ORLANDO, FLORIDA / ACCESS Newswire / April 8, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech comp...

19 days ago - Accesswire

Exousia Pro Issues Update on Name Change

ORLANDO, FLORIDA / ACCESS Newswire / April 3, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other dis...

24 days ago - Accesswire

Exousia Pro Has Appointed Matthew Dwyer As Its New President

ORLANDO, FL / ACCESS Newswire / April 2, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...

25 days ago - Accesswire

Exousia Pro Issues and Update on its FDA Orphan Drug Status

ORLANDO, FL / ACCESS Newswire / April 1, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...

26 days ago - Accesswire

Exousia Pro Officially Announces the Production of Plant-Based Exosomes Has Begun

Exousia Pro will be sending out samples to clients expected to place orders ORLANDO, FL / ACCESS Newswire / March 25, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., announces the offici...

4 weeks ago - Accesswire

Exousia Has Successfully Renegotiated Its License Agreement

ORLANDO, FL / ACCESS Newswire / March 18, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies, is...

5 weeks ago - Accesswire